Since RAS-GAPs were frequently inactivated by epigenetic mechanism19,21, we also detected the epigenetic status of RASAL2 and found a negative correlation between RASAL2 mRNA and DNA promotor methylation in RCC. This evidence concerns the gene RASAL2 and renal cell carcinoma.